New combo may be safer for elderly heart patients after stenting
NCT ID NCT06451198
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two blood thinner combinations in adults over 65 who have had a heart attack or unstable angina and received a stent. One group gets indobufen plus ticagrelor, the other gets aspirin plus ticagrelor. The goal is to see which combo better prevents heart-related events and serious bleeding over one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Hospital Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Marathon runners and heart patients put a new troponin test to the ultimate challenge
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Bedside flu shot for heart patients: a simple strategy to save lives?
- Step by step: a coaching program aims to keep heart patients moving after rehab
- Heart bypass upgrade: which Artery-Harvesting technique works best?